Advanced Research Training in Transplantation Science
Advanced Research Training in Transplantation Science
批准号:
9359535
负责人:
Mandy L Ford
金额:
$17.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2022-07-31
中文摘要
摘要
这一竞争性续延旨在为11-15年的成功机构培训赠款提供资金,重点是
器官和组织移植的科学。移植科学高级研究培训
埃默里大学(Emory University)的ARTTS计划服务于医学科学,移植生物学领域,即
非常严格,独特的多学科,迫切需要新的学生来承担大量的
这是过去20年来形成的势头。该申请旨在资助1名前博士和2名博士后
学员每年一名,个别委任为期两年。它旨在培养受训人员,
在移植生物学领域建立独立的研究计划。自2006年成立以来,
项目已成功招收和培养了6名博士预科生和9名博士后。的6
博士前ARTTS学员谁已经完成培训,100%有第一作者出版物的结果,
他们的研究生研究,第一作者和总出版物的平均数量为2.67
(范围1-4)和5.17(范围1-9)。在过去的6名博士后ARTTS学员中,
完成培训,100%的博士后研究结果是第一作者出版物,
该组的第一作者和总出版物的平均数量分别为1.9(范围1-6)和4.3(范围2-8),
分别此外,93.3%的ARTTS计划学员从事研究密集型职业或仍在从事研究密集型职业。
训练因此,该计划在招募和培训下一代方面非常成功。
移植科学家目前的提案代表了一个高度专业化的团队的持续承诺,
富有成效的,多样化的,积极合作的初级和高级研究员/导师,与相关的小组
专门的教师,在一个强大的机构基础上的基本学术卓越,执行一个
独特和精心设计的培训计划,将继续吸引和留住积极性高的学员
移植领域,并给予他们独特的工具集,需要影响的普遍问题,
领域在当前的应用中,我们提出进一步增强基本的,
通过提供临床和转化科学方面的正规培训,
分析学、生物信息学和临床试验设计。因此,ARTTS计划现在提供了令人难以置信的丰富内容
在移植和病毒免疫学中,环境跨越强大的小鼠模型,
翻译计划在耶基斯国家灵长类动物中心,并显着增加的机会,在临床
临床试验和人体免疫学该计划继续发展,以更好地吸引高素质的候选人
来自全国各地代表了种族和民族的多样性,重要的是现在提供了一项研究,
重点关注少数群体在移植方面的健康差异。因此,目前的产品是在切割
移植科学培训的边缘,无疑将有助于改善移植科学的未来
移植研究和实践,并优化移植受体的寿命和生活质量。
英文摘要
Abstract
This competitive renewal seeks funding for years 11-15 of a successful institutional training grant focusing on
the science of organ and tissue transplantation. The Advanced Research Training in Transplantation Sciences
(ARTTS) program at Emory University serves an area of medical science, transplantation biology, that is
exceptionally rigorous, uniquely multidisciplinary, and in dire need of new students to take up the substantial
momentum established in the past 20 years. The application seeks to fund 1 pre-doctoral and 2 post-doctoral
trainees each year, and individual appointments will last for 2 years. It seeks to produce trainees that go on to
establish independent research programs in the area of transplantation biology. Since its inception in 2006, the
program has successfully recruited and trained 6 pre-doctoral trainees and 9 post-doctoral trainees. Of the 6
pre-doctoral ARTTS trainees who have completed training, 100% had a first author publication as a result of
their graduate research, and the average numbers of first author and total publications for this group was 2.67
(range 1-4) and 5.17 (range 1-9), respectively. Of the 6 past post-doctoral ARTTS trainees who have
completed training, 100% had a first author publication as a result of their post-doctoral research, and the
average numbers of first author and total publications for this group was 1.9 (range 1-6) and 4.3 (range 2-8),
respectively. Furthermore, 93.3% of ARTTS Program trainees are in research-intensive careers or are still in
training. Thus, the program has been highly successful in recruiting and training the next generation of
transplantation scientists. The current proposal represents the continued commitment of a team of highly
productive, diverse, and actively collaborating junior and senior investigator/mentors, with an associated group
of dedicated instructors, on a strong institutional foundation of fundamental academic excellence, to execute a
unique and carefully designed training program that will continue to attract and retain highly motivated trainees
to the transplantation field, and give them the unique tool set needed to influence the prevailing problems in the
field. In the current application we propose to further enhance communication and collaboration between basic,
translational, and clinical transplantation sciences by offering formal training in clinical and translational science
analytics, bioinformatics, and clinical trial design. The ARTTS Program thus now offers an incredibly rich
environment spanning powerful murine models in transplantation and viral immunology, an intensive
translational program at the Yerkes National Primate Center, and markedly augmented opportunities in clinical
trials and human immunology. The program continues to evolve to better attract highly qualified candidates
from across the country representing a diversity of races and ethnicities, and importantly now offers a research
focus on health disparities among minority groups in transplantation. Thus, the current offering is on the cutting
edge of training in transplantation sciences, and undoubtedly will contribute to improving the future of
transplantation research and practice, and optimizing both length and quality of life for transplant recipients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanotechnology Targeting Novel CD154:CD11b Interactions for Transplant Tolerance
-
批准号:10622211
-
项目类别:
-
资助金额:$106.46万
-
财政年份:2023
-
负责人:Mandy L Ford
-
依托单位:
Determinants of T Cell Fate in Transplantation Tolerance
-
批准号:10539825
-
项目类别:
-
资助金额:$71.5万
-
财政年份:2022
-
负责人:Mandy L Ford
-
依托单位:
Determinants of T Cell Fate in Transplantation Tolerance
-
批准号:10672382
-
项目类别:
-
资助金额:$71.5万
-
财政年份:2022
-
负责人:Mandy L Ford
-
依托单位:
CD11b: A Novel Alternate Receptor for CD154 during Alloimmunity
-
批准号:10571694
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Mandy L Ford
-
依托单位:
CD11b: A Novel Alternate Receptor for CD154 during Alloimmunity
-
批准号:10666184
-
项目类别:
-
资助金额:$4.51万
-
财政年份:2020
-
负责人:Mandy L Ford
-
依托单位:
Role of TIGIT Signaling in Transplantation
-
批准号:10228813
-
项目类别:
-
资助金额:$67.17万
-
财政年份:2020
-
负责人:Mandy L Ford
-
依托单位:
CD11b: A Novel Alternate Receptor for CD154 during Alloimmunity
-
批准号:10356115
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Mandy L Ford
-
依托单位:
CD11b: A Novel Alternate Receptor for CD154 during Alloimmunity
-
批准号:10728916
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2020
-
负责人:Mandy L Ford
-
依托单位:
Memory T Cell Cosigning Pathways in Sepsis-Induced Immune Dysregulation
-
批准号:10079469
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2015
-
负责人:Mandy L Ford
-
依托单位:
Memory T Cell Cosigning Pathways in Sepsis-Induced Immune Dysregulation
-
批准号:9887580
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2015
-
负责人:Mandy L Ford
-
依托单位:
Memory T Cell Cosigning Pathways in Sepsis-Induced Immune Dysregulation
-
批准号:10323009
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2015
-
负责人:Mandy L Ford
-
依托单位:
Memory T Cell Cosigning Pathways in Sepsis-Induced Immune Dysregulation
-
批准号:10539291
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2015
-
负责人:Mandy L Ford
-
依托单位:
Costimulatory and Coinhibitory Receptor Control of Alloreactive T Cell Responses
-
批准号:8827578
-
项目类别:
-
资助金额:$5.49万
-
财政年份:2014
-
负责人:Mandy L Ford
-
依托单位:
Costimulatory and Coinhibitory Receptor Control of Alloreactive T Cell Responses
-
批准号:8594695
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2013
-
负责人:Mandy L Ford
-
依托单位:
Costimulatory and Coinhibitory Receptor Control of Alloreactive T Cell Responses
-
批准号:8839200
-
项目类别:
-
资助金额:$44.49万
-
财政年份:2013
-
负责人:Mandy L Ford
-
依托单位:
Antigen Density Critically Impacts T Cell Programming During Transplantation
-
批准号:7764668
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:Mandy L Ford
-
依托单位:
Antigen Density Critically Impacts T Cell Programming During Transplantation
-
批准号:7513527
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2009
-
负责人:Mandy L Ford
-
依托单位:
Donor-Reactive Memory Responses and Recall Requirements in Transplantation
-
批准号:7916915
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:Mandy L Ford
-
依托单位:
Determinants of T Cell Fate in Transplantation
-
批准号:7921768
-
项目类别:
-
资助金额:$17.83万
-
财政年份:2009
-
负责人:Mandy L Ford
-
依托单位:
Determinants of T Cell Fate in Transplantation
-
批准号:7881608
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2008
-
负责人:Mandy L Ford
-
依托单位:
国内基金
海外基金
登录
查看更多内容
科学传播类:基于大科学装置“中国天眼”的AI for science新型科普平台建设
-
批准号:T2241020
-
项目类别:专项项目
-
资助金额:10.00万元
-
批准年份:2022
-
负责人:毛睿
-
依托单位:
SCIENCE CHINA: Earth Sciences
-
批准号:41224003
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:魏建晶
-
依托单位:
SCIENCE CHINA Chemistry
-
批准号:21224001
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:朱晓文
-
依托单位:
基于e-Science的民族信息资源融合与语义检索研究
-
批准号:61262071
-
项目类别:地区科学基金项目
-
资助金额:46.0万元
-
批准年份:2012
-
负责人:甘健侯
-
依托单位:
Frontiers of Environmental Science & Engineering
-
批准号:51224004
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2012
-
负责人:朱建军
-
依托单位:
Science China-Physics, Mechanics & Astronomy
-
批准号:11224804
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:黄延红
-
依托单位:
Journal of Computer Science and Technology
-
批准号:61224001
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2012
-
负责人:万晓霰
-
依托单位:
SCIENCE CHINA Information Sciences
-
批准号:61224002
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:宋扉
-
依托单位:
SCIENCE CHINA Technological Sciences
-
批准号:51224001
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:安梅
-
依托单位:
SCIENCE CHINA Life Sciences (中国科学 生命科学)
-
批准号:81024803
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:李纪元
-
依托单位: